Caliber Wealth Management (Kansas)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42M Buy
2,017
+1,343
+199% +$1.37M 0.23% 82
2026
Q1
$620K Buy
674
+84
+14% +$85.2K 0.07% 159
2025
Q4
$634K Buy
590
+96
+19% +$91.8K 0.07% 159
2025
Q3
$377K Sell
494
-382
-44% -$284K 0.04% 195
2025
Q2
$683K Buy
876
+169
+24% +$131K 0.07% 157
2025
Q1
$584K Buy
+707
New +$588K 0.08% 153

Other funds holding LLY

Caliber Wealth Management (Kansas)'s LLY Position: Q2 2026 in Review

Caliber Wealth Management (Kansas) increased its Eli Lilly (LLY) stake by 199% in Q2 2026, buying an estimated $1.37M and bringing the position to 2,017 shares worth $2.42M. The position accounts for 0.23% of the portfolio, ranked #82.

Caliber Wealth Management (Kansas) first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 1,768 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Caliber Wealth Management (Kansas) held 2,017 shares of Eli Lilly worth $2.42M as of Q2 2026.
  • Caliber Wealth Management (Kansas) bought 1,343 Eli Lilly shares in Q2 2026, an estimated $1.37M.
  • Eli Lilly made up 0.23% of Caliber Wealth Management (Kansas)'s portfolio in Q2 2026, its #82 holding.
  • Caliber Wealth Management (Kansas) first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 1,768 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Caliber Wealth Management (Kansas)'s 13F filing for Q2 2026, filed 22 Jul 2026.